Agilent

Agilent Technologies' bioinformatics suite to enable standardization of platforms at federal agency

2006-10-24T14:41:00Z

SANTA CLARA, Calif., Oct. 23, 2006

Agilent Technologies Inc. (NYSE: A) announced today that the National Cancer Institute (NCI) has purchased a full site license for a wide range of Agilent bioinformatics solutions.

Under the agreement, the NCI is making the following solutions available to its intramural program researchers: Agilent GeneSpring GX for gene expression, Agilent CGH Analytics for comparative genomic hybridization (CGH) studies, Agilent Chip Analytics to analyze chromatin immunoprecipitation-on-chip data (ChIP-on-chip), and GeneSpring GT for genotyping and SNP analysis.

The license, arranged under the auspices of the NCI's Office of Science and Technology Partnerships, will enable standardization of bioinformatics platforms so that users communicate using the same terms and share comparable training and support.

"We're proud of our close working relationship with the NCI," said Agilent's Jordan Stockton, gene expression marketing manager, "especially in helping their researchers employ such emerging applications as aCGH and ChIP-on-chip in conjunction with gene expression to accelerate the search for ways of controlling cancer."

Agilent GeneSpring GX 7.3, the leading desktop gene-expression analysis solution, is designed to help researchers to identify targets quickly and reliably. Statistically meaningful results provide the ability to predict clinical outcomes and to characterize novel expression patterns.

Agilent CGH Analytics 3.4 lets researchers visually explore, detect and analyze aberration patterns from multiple CGH microarray profiles. Agilent ChIP Analytics 1.2 lets users visually explore and analyze data from Agilent ChIP-on-chip microarrays.

Agilent GeneSpring GT 2.0 is a desktop analysis workbench for analyzing high-volume, high-density genotyping data. A comprehensive set of linkage and association algorithms allows researchers to discover relationships between genotypes and phenotypes. Designed for biologists and statisticians, GeneSpring GT enables analysis and visualization of hundreds of thousands of variation measurements simultaneously, for rapid localization of disease or phenotype markers.

For complete details about Agilent's bioinformatics solutions, visit www.chem.agilent.com.

About the Technology

Oligonucleotide microarrays comprise short sequences of nucleotides, often used as probes for detecting complementary DNA or RNA. Array CGH technology provides a way of studying chromosomal aberrations, including copy number changes and rearrangements, across the entire genome simultaneously. Ultimately, this information can be used to determine gene activity or to pinpoint chromosomal abnormalities such as gains or losses associated with disease states.

About Agilent in Genomics

Agilent is a leading worldwide provider of microarray-based, genomics research solutions. Agilent's end-to-end solution includes reagents for sample preparation and microarray processing; hardware for sample QC and high-throughput microarray scanning; 60-mer oligo microarrays on industry-standard 1" x 3" glass slides for gene expression; comparative genomic hybridization and chromatin immunoprecipitation applications; custom microarray design services; and industry-leading GeneSpring.

About Agilent Technologies

Agilent Technologies Inc. (NYSE: A) is the world's premier measurement company and a technology leader in communications, electronics, life sciences and chemical analysis. The company's 20,000 employees serve customers in more than 110 countries. Agilent had net revenue of $5.1 billion in fiscal 2005. Information about Agilent is available on the Web at www.agilent.com.

# # #

Contact:

John Watson
+1 408 553 7205
j_watson@agilent.com

Agilent Technologies joins BioIT Alliance

2006-10-20T04:23:00Z

Agilent Technologies today announced that it has joined the BioIT Alliance, a cross-industry group working together to improve biomedical information technology.

The Alliance seeks to enable the pharmaceutical, biotechnology, equipment manufacturing and software industries to share best practices and develop standards for sharing biomedical data, improving collaboration and effectively managing life sciences knowledge. The early focus of the Alliance has been on addressing data-capture and data-integration challenges that hinder the adoption of emerging life science technologies.

As a member of the alliance, Agilent will collaborate with other members on proof-of-concept applications that address critical bottlenecks in biomedical discovery. Included is the alliance's latest proof-of-concept, the Biomarkers Project, designed to simplify the process of identifying and validating genomic biomarkers, the characteristics that indicate the presence of a disease or the likely efficacy of a drug.

"Agilent's involvement in the BioIT Alliance will further strengthen our commitment to enable biotechnology and pharmaceutical companies to effectively integrate data and insights from multiple disciplines and measurement platforms," said Nick Roelofs, vice president and general manager of life sciences, Agilent Technologies.

For more information about Agilent's life sciences and chemical analysis solutions, visit www.chem.agilent.com.

About the BioIT Alliance

Formed in 2006, the BioIT Alliance is a cross-industry group working together to improve biomedical information technology on the Microsoft platform. Additional information about the BioIT Alliance can be found on the BioIT Alliance Web site at www.bioitalliance.org.

About Agilent Technologies

# # #

Contact:

John Watson
+1 408 553 7205
j_watson@agilent.com

News Releases

2006-10-16T20:51:00Z

Life Science and Chemical Analysis news releases.

New on Agilent's Web Site

2006-10-16T20:50:00Z

Recent additions to Agilent's Life Science and Chemical Analysis website.

Agilent's Literature Library

2006-10-16T20:45:00Z

See Agilent's online literature library.

GeneSpring

2006-10-16T15:03:00Z

The Agilent GeneSpring Analysis Platform is specifically developed to answer biological questions at the intersection of genomics, genetics, proteomics, and biomarker screening. Designed to integrate data and results from multiple applications, the platform provides comprehensive statistical analysis, data mining, and visualization tools to answer a wide range of research questions.

Informatics and Software

2006-10-10T23:13:00Z

Solutions for the complete lifecycle of analytical information

Agilent's series of strategic acquisitions including Scientific Software, Inc., Computational Biology Corporation, and Silicon Genetics has expanded and strengthened our portfolio of informatics software for the life science and chemical industries. The integration of these software solutions addresses the complete lifecycle of analytical information - from data acquisition to knowledge management and analysis. Agilent's combined software products give you access to an open system architecture that can integrate applications, instruments, and data into a rich source of information and control of your lab - regardless of vendor.

Lab-on-a-Chip Products

2006-10-10T23:08:00Z

Cutting edge Lab-on-a-Chip Products

Agilent Technologies is the leader in commercial microfluidic Lab-on-a-Chip technology. This technology utilizes a network of channels and wells that are etched onto glass or polymer chips to build mini-labs. Pressure or electrokinetic forces move pico liter volumes in finely controlled manner through the channels. Lab-on-a-Chip enables sample handling, mixing, dilution, electrophoresis and chromatographic separation, staining and detection on single integrated systems. The main advantages of Lab-on-a-Chip are ease-of-use, speed of analysis, low sample and reagent consumption and high reproducibility due to standardization and automation.

DNA Microarrays

2006-10-10T23:05:00Z

Agilent Printed Microarray Solutions are based on an integrated, flexible, open approach for successful gene expression analysis. Each component is designed to work with others in our system, or with your existing set-up. Allowing you to express it your way. Buy just what you need or purchase the entire system.

Agilent in the Life Sciences

2006-10-10T22:45:00Z

Visit Agilent's Life Science and Chemical Analysis site for information about Agilent's life science products and services.